Bleakley Financial Group LLC Purchases 11,913 Shares of KKR & Co. Inc. (NYSE:KKR)

Bleakley Financial Group LLC boosted its position in KKR & Co. Inc. (NYSE:KKR) by 42.8% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 39,724 shares of the asset manager’s stock after buying an additional 11,913 shares during the period. Bleakley Financial Group LLC’s holdings in KKR & Co. Inc. were worth $5,187,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in the company. Benjamin F. Edwards & Company Inc. boosted its stake in KKR & Co. Inc. by 13.1% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 769 shares of the asset manager’s stock valued at $81,000 after purchasing an additional 89 shares during the period. Crestwood Advisors Group LLC raised its holdings in KKR & Co. Inc. by 2.1% in the 2nd quarter. Crestwood Advisors Group LLC now owns 4,658 shares of the asset manager’s stock valued at $490,000 after acquiring an additional 94 shares in the last quarter. Centaurus Financial Inc. raised its holdings in KKR & Co. Inc. by 1.3% in the 2nd quarter. Centaurus Financial Inc. now owns 7,715 shares of the asset manager’s stock valued at $812,000 after acquiring an additional 98 shares in the last quarter. Premier Path Wealth Partners LLC raised its holdings in KKR & Co. Inc. by 2.4% in the 2nd quarter. Premier Path Wealth Partners LLC now owns 4,231 shares of the asset manager’s stock valued at $445,000 after acquiring an additional 99 shares in the last quarter. Finally, Whittier Trust Co. raised its holdings in KKR & Co. Inc. by 4.5% in the 1st quarter. Whittier Trust Co. now owns 2,395 shares of the asset manager’s stock valued at $241,000 after acquiring an additional 103 shares in the last quarter. 76.26% of the stock is currently owned by institutional investors.

Insider Activity

In other news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $25.75, for a total value of $149,350,000.00. Following the completion of the sale, the insider now owns 25,260,971 shares of the company’s stock, valued at approximately $650,470,003.25. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $25.75, for a total value of $149,350,000.00. Following the completion of the sale, the insider now owns 25,260,971 shares of the company’s stock, valued at approximately $650,470,003.25. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, major shareholder Kkr Group Partnership L.P. sold 2,554,644 shares of the stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $18.85, for a total value of $48,155,039.40. The disclosure for this sale can be found here. Insiders own 39.34% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Redburn Atlantic assumed coverage on KKR & Co. Inc. in a report on Tuesday, August 27th. They issued a “buy” rating and a $153.00 price objective for the company. Keefe, Bruyette & Woods reaffirmed an “outperform” rating and issued a $144.00 price objective (up from $125.00) on shares of KKR & Co. Inc. in a report on Thursday, August 1st. Oppenheimer boosted their price target on KKR & Co. Inc. from $128.00 to $148.00 and gave the stock an “outperform” rating in a report on Wednesday. Evercore ISI boosted their price target on KKR & Co. Inc. from $135.00 to $145.00 and gave the stock an “outperform” rating in a report on Monday. Finally, JMP Securities boosted their price target on KKR & Co. Inc. from $135.00 to $150.00 and gave the stock a “market outperform” rating in a report on Wednesday, October 9th. One research analyst has rated the stock with a sell rating, two have given a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, KKR & Co. Inc. has an average rating of “Moderate Buy” and an average price target of $144.43.

KKR & Co. Inc. Price Performance

KKR & Co. Inc. stock opened at $137.81 on Friday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.86. The company has a market capitalization of $122.29 billion, a PE ratio of 30.90, a P/E/G ratio of 1.14 and a beta of 1.62. KKR & Co. Inc. has a 12 month low of $53.72 and a 12 month high of $139.82. The stock has a 50-day moving average price of $125.64 and a two-hundred day moving average price of $112.30.

KKR & Co. Inc. (NYSE:KKR) last posted its earnings results on Wednesday, July 31st. The asset manager reported $1.09 EPS for the quarter, beating the consensus estimate of $0.89 by $0.20. The firm had revenue of $4.17 billion during the quarter, compared to the consensus estimate of $1.07 billion. KKR & Co. Inc. had a return on equity of 5.05% and a net margin of 17.99%. During the same period last year, the company earned $0.58 earnings per share. Analysts expect that KKR & Co. Inc. will post 3.97 EPS for the current year.

KKR & Co. Inc. Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, August 27th. Stockholders of record on Monday, August 12th were paid a $0.175 dividend. The ex-dividend date was Monday, August 12th. This represents a $0.70 annualized dividend and a dividend yield of 0.51%. KKR & Co. Inc.’s payout ratio is 15.70%.

KKR & Co. Inc. Company Profile

KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.